As the epidemic spread and became a pandemic it was apparent that children are infected at similar rates as adults, but with much lower rates of hospitalization. I will also discuss the vaccines developed at record speed and their efficacy in protecting children from disease.ġ. Predominantly mild COVID-19 infection in children and young peopleĪlready early during the first wave of SARS-CoV-2 transmission in Wuhan, China a milder disease presentation in children and young people was noted among hospitalized patients with the new illness, COVID-19. Here I will discuss some of the findings made to explain these diverse disease manifestations in children and young people infected by SARS-CoV-2. It has also become clear that this is not universally true, as some children develop severe COVID-19 hypoxic pneumonia and even succumb to the infection, while another group of children develop a rare but serious multisystem inflammatory syndrome (MIS-C) and some other children experience prolonged illness following acute infection, post-COVID. A general theme throughout the pandemic has been the observation that children and young people in general fare well, with mild symptoms during acute infection and full recovery thereafter. During the three years since SARS-CoV-2 infections were first described a wealth of information has been gathered about viral variants and their changing properties, the disease presentations they elicit and how the many vaccines developed in record time protect from COVID-19 severe disease in different populations.

Russell peters pala casino